Proceed with Confidence

Exclusive Offers

Shire is committed to making life easier for people with partial and generalized seizures—and for the people who care for them—by providing useful information about epilepsy and its treatment. Understanding epilepsy is an important part of your commitment to seizure control; the more you know about your condition, the better you will be able to work with your doctor and other health care professionals to achieve this goal.

Simply select the exclusive offers you are interested in and click Submit.

Download a Carbatrol Resource Pack: (zip file)

View a resource to help your patients learn more about epilepsy, how Carbatrol works and the particular challenges women and children with the disease may face.

Learn More

Request a "Taking Control of Epilepsy" DVD:
(Free—mailed to your physical address.)

View an informative and inspiring half-hour TV documentary featuring interviews with leading epileptologists and profiles of everyday people living with epilepsy.

Learn More

I acknowledge that I am 13 years of age or older.


FACT

Carbatrol Is a Recognized Leader

Carbamazepine, the ingredient in Carbatrol, remains an effective drug for the treatment of partial and generalized seizures.

Anticonvulsants should be taken in the manner and at the times prescribed by the physician.

Important Safety Information for Patients and Caregivers

  • Carbatrol® contains carbamazepine. If you are currently taking another medication that contains carbamazepine, do not begin taking Carbatrol without discussing this with your healthcare provider.
  • If you are taking any other medications, including oral contraceptives, over-the-counter medications, or herbal products, be sure to inform your healthcare provider, as Carbatrol can interact with other medications.
  • Carbatrol was generally well tolerated in clinical studies. The most common side effects, particularly when first starting on Carbatrol, were dizziness, drowsiness, unsteadiness, nausea, and vomiting.
  • Serious skin disorders have been reported with use of carbamazepine. These skin disorders may be more common in patients of Asian ancestry. Patients of Asian ancestry who have a specific gene (HLA-B*1502) may be at increased risk. Patients of Asian ancestry should be tested for this gene prior to starting Carbatrol.
  • Contact your healthcare provider if you have any unexplained bruising, fever, or infection. Products that contain carbamazepine have been associated with rare but serious types of blood disorders.
  • Carbamazepine can cause fetal harm. Contact your healthcare provider if you are considering becoming pregnant, or are pregnant, in order to discuss the continued benefits and risks.
  • People with a history of bone marrow problems, or who are allergic to carbamazepine, or who are sensitive to tricyclic antidepressants should not take Carbatrol.
  • Certain types of seizures (absence seizures or petit mal) do not appear to be controlled by carbamazepine.

See Important Safety Information for Patients & Caregivers

Carbatrol® is registered in the United States Patent and Trademark Office.

©2008 Shire US Inc., Wayne, PA 19087-5367
(800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

C510 01/04/2008